Chargement en cours...
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
Radical cure of Plasmodium vivax malaria in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals employs weekly primaquine dosing. This is the only recommended regimen for this patient sub-group. If national malaria programs mandate daily primaquine dosing (the recommended regimen for G6PD...
Enregistré dans:
| Publié dans: | Wellcome Open Res |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
F1000 Research Limited
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6480970/ https://ncbi.nlm.nih.gov/pubmed/31069260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15100.2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|